Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany.

MedImmune develops medicines for unmet medical needs worldwide. As the global biologics research and development arm of AstraZeneca, MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic including respiratory, inflammation, and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. Since its founding in 1988, MedImmune has remained committed to scientific innovation and medical progress, continually looking beyond standard expectations and pushing the boundaries of what is possible.

At Cradle Genomics, their mission is to provide knowledge that helps every pregnancy. They're dedicated to the transformation of non-invasive prenatal testing (NIPT) by offering the most comprehensive fetal genetic analysis and pregnancy health screening solutions at the earliest stages of pregnancy. Cradle Genomics is newly formed with their headquarters based in San Diego and additional R&D operations located in Detroit. Cradle tests are based on the genetic analysis of fetal cells that are quickly collected during a first trimester visit with no risk to the mother or developing fetus.

SK bioscience Co., Ltd. engages in the development and distribution of bio and vaccine products. The company was founded on July 1, 2018 and is headquartered in Seongnam-si, South Korea.

Genetics Institute is a U.S. based biotechnology research and development company. The company developed drugs such as Neumega and Recombinate used in the prevention of severe reductions in the number of blood clotting cells. The company was founded in 1980 by Thomas Maniatis and Mark Ptashne, and started off by operating out of Ptashne’s home. Genetics Institute was acquired by Wyeth in 1992 and operates as part of Wyeth’s research division.

Xi'an Kewei Medical Technology Co., Ltd., established on 2010-05-14, Business scope includes licensed business items:Class II medical device;Three categories;Extracorporeal circulation and blood treatment equipment,Implantable materials and artificial organs,Intervention equipment,Sales of medical polymer materials and products(The above-mentioned business scope involves licensed business items,Operate within the validity period with the license certificate or approval certificate,Do not operate without permission).General operating items:R & D and sales of health care products(Does not contain health food).(The above business scope excludes the special control and pre-licensing projects stipulated by the state)

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Tianjin Kangting Bioengineering Group Co., Ltd., established on 1996-09-09, Business scope includes cosmetics,Production of hygiene products,manufacture,processing,Sales;Sell ​​dropshipping products in dropshipping style142kind(The product list is subject to the direct sales product list approved by the Ministry of Commerce);food production,Sales;Wujinjiaodian,Chemical Products(Hazardous chemicals and precursor chemicals are excluded),Daily necessities,building materials,Decoration materials,department store,household appliances,Health Products Sales;Hotel Management Services;General cargo transportation;Business Management Consulting Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Institutes for Biological Sciences CAS is a private company headquartered in Shanghai, China, that operates as researching agency.

Genetalks is a genetic technology-based medical and health solution supplier of solutions. A few examples of technology-driven industrial innovation are medical diagnosis, smart health management, and big data in gene health.

JFK Biotech develops products for molecular diagnosis and rapid self-test technology. They also offer a series of products for early screening, early diagnosis, and early treatment of pulmonary nodules, lung cancer, COPD, asthma, airway inflammation, and airway infection.

SFRI is a manufacturer and exporter of in vitro diagnostic instruments.

Chengdu Xingenge Biotechnology Co., Ltd., established on 2006-11-21, Business scope includes licensed projects:Class III medical device business;Import and export;Technology Import and Export;The second type of value-added telecommunications services(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Development of Human Gene Diagnosis and Therapy Technology;Instrument sales;Sales of Class I Medical Devices;Sales of Class II Medical Devices;software development;software sales;Technology intermediary service;Machinery and Equipment Leasing;Storage equipment rental service;Medical equipment rental;Transportation equipment rental service;Office equipment rental service;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Computer and communication equipment rental(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.

SolGent Co., Ltd. provides solutions for molecular biology, molecular diagnostics and genetics. Its business areas are Molecular Diagnosis, Molecular Biology and Genetic Analysis Service. The firm's Molecular Diagnosis business develops pathogen detection and human genotype kit and microbial screening, Molecular Biology research offers amplification, cloning, and biological reagents and the Genetic Analysis Service provides sequencing, genotyping, DNA fingerprinting, and microorganism identification service. The company was founded in 2000 and is headquartered in Daejeon, South Korea.

Biometrix Technology, Inc. supplies DNA testing products. It makes oligonucleotide DNAChips and genotyping kits for early detection of viral or bacterial infections. The firm’s products include BMT HPV 9G DNA Kit and BMT HPV Genotyping 9G DNA Membrane Kit. The company was founded on October 04, 2000 and is headquartered in Chuncheon, South Korea.